CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 180 filers reported holding CHEMOCENTRYX INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $92,609,000 | +108.5% | 1,792,657 | 0.0% | 0.61% | +140.5% |
Q2 2022 | $44,422,000 | +93.3% | 1,792,657 | +95.5% | 0.25% | +90.9% |
Q1 2022 | $22,986,000 | -61.3% | 916,862 | -43.8% | 0.13% | -54.3% |
Q4 2021 | $59,394,000 | +1053.3% | 1,631,266 | +441.6% | 0.29% | +1156.5% |
Q3 2021 | $5,150,000 | -84.7% | 301,195 | -54.1% | 0.02% | -84.2% |
Q1 2021 | $33,650,000 | -17.2% | 656,710 | 0.0% | 0.15% | -4.6% |
Q4 2020 | $40,663,000 | -17.5% | 656,710 | -27.0% | 0.15% | -22.3% |
Q3 2020 | $49,310,000 | -9.3% | 899,821 | -4.8% | 0.20% | -17.9% |
Q2 2020 | $54,388,000 | +57.6% | 945,221 | +10.0% | 0.24% | +12.7% |
Q1 2020 | $34,515,000 | +18.1% | 859,015 | +16.2% | 0.21% | +37.4% |
Q4 2019 | $29,228,000 | +1981.8% | 739,016 | +257.0% | 0.16% | +1450.0% |
Q3 2019 | $1,404,000 | -27.1% | 207,029 | 0.0% | 0.01% | -23.1% |
Q2 2019 | $1,925,000 | -33.1% | 207,029 | 0.0% | 0.01% | -27.8% |
Q1 2019 | $2,876,000 | +27.3% | 207,029 | 0.0% | 0.02% | 0.0% |
Q4 2018 | $2,259,000 | -56.8% | 207,029 | -50.0% | 0.02% | -47.1% |
Q3 2018 | $5,233,000 | -4.0% | 414,029 | 0.0% | 0.03% | -17.1% |
Q2 2018 | $5,453,000 | -3.2% | 414,029 | 0.0% | 0.04% | -14.6% |
Q1 2018 | $5,631,000 | +1828.4% | 414,029 | +743.9% | 0.05% | +1500.0% |
Q4 2017 | $292,000 | -19.8% | 49,064 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $364,000 | -20.7% | 49,064 | 0.0% | 0.00% | -25.0% |
Q2 2017 | $459,000 | +28.6% | 49,064 | 0.0% | 0.00% | +33.3% |
Q1 2017 | $357,000 | -1.7% | 49,064 | 0.0% | 0.00% | -25.0% |
Q4 2016 | $363,000 | +22.6% | 49,064 | 0.0% | 0.00% | +33.3% |
Q3 2016 | $296,000 | +34.5% | 49,064 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $220,000 | +80.3% | 49,064 | 0.0% | 0.00% | +100.0% |
Q1 2016 | $122,000 | -69.3% | 49,064 | 0.0% | 0.00% | -66.7% |
Q4 2015 | $397,000 | +33.7% | 49,064 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $297,000 | -26.5% | 49,064 | 0.0% | 0.00% | -25.0% |
Q2 2015 | $404,000 | +9.2% | 49,064 | 0.0% | 0.00% | +33.3% |
Q1 2015 | $370,000 | +8.2% | 49,064 | -1.9% | 0.00% | 0.0% |
Q4 2014 | $342,000 | +52.0% | 50,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $225,000 | -23.2% | 50,000 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $293,000 | -11.7% | 50,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $332,000 | +14.5% | 50,000 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $290,000 | -73.9% | 50,000 | -75.0% | 0.00% | -75.0% |
Q3 2013 | $1,112,000 | -79.0% | 200,000 | -46.7% | 0.02% | -84.8% |
Q2 2013 | $5,303,000 | – | 375,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
Birchview Capital, LP | 25,000 | $428,000 | 0.29% |